Antibacterial activity of the emerging Fusarium mycotoxins enniatins A, A₁, A₂, B, B₁, and B₄ on probiotic microorganisms

Toxicon. 2014 Jul:85:1-4. doi: 10.1016/j.toxicon.2014.04.007. Epub 2014 Apr 19.

Abstract

Enniatins (ENs) are secondary metabolites produced by several Fusarium strains, chemically characterized as N-methylated cyclohexadepsipeptides. These compounds are known to act as antifungal and antibacterial agents, but they also possess anti-insect and phytotoxic properties. In this study, the antimicrobial effect of pure fractions of the bioactive compounds ENs A, A₁, A₂, B, B₁, and B₄ was tested towards nine probiotic microrganisms, twenty-two Saccharomyces cerevisiae strains and nine Bacillus subtilis strains. Antimicrobial analyses were carried out the disc-diffusion method using ENs concentrations ranging from 0.2 to 20,000 ng. Plates were incubated for 24 h at 37 °C before reading the diameter of the inhibition spots. ENs A, A₁, A₂, B, B₁ and B₄, were active against several microorganisms with inhibition halos ranging from 3 to 12 mm in diameter. The most active mycotoxin was the EN A₁, which reduced the microbial growth of 8 strains at the dose of 20,000 ng, with inhibition spots sized between 8 and 12 mm. ENs B and B₄ showed no antimicrobial activity towards the microorganisms tested at doses up to 20,000 ng per disc.

Keywords: Antimicrobial activity; Bacillus subtilis; Enniatins; Probiotic bacteria; Saccharomyces cerevisiae.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / biosynthesis
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / toxicity
  • Bacillus subtilis / drug effects*
  • Bacillus subtilis / growth & development
  • Bacillus subtilis / isolation & purification
  • Depsipeptides / biosynthesis
  • Depsipeptides / pharmacology*
  • Depsipeptides / toxicity
  • Disk Diffusion Antimicrobial Tests
  • Drug Resistance, Multiple, Bacterial
  • Food Contamination
  • Fusarium / metabolism*
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / microbiology
  • Humans
  • Models, Biological*
  • Mycotoxins / biosynthesis
  • Mycotoxins / pharmacology*
  • Mycotoxins / toxicity
  • Probiotics
  • Saccharomyces cerevisiae / drug effects*
  • Saccharomyces cerevisiae / growth & development
  • Saccharomyces cerevisiae / isolation & purification
  • Structure-Activity Relationship

Substances

  • Anti-Bacterial Agents
  • Depsipeptides
  • Mycotoxins
  • enniatins